Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

From the College

Coding Corner Questions: A Drug Administration Quiz

From the College  |  November 19, 2018

A 70–year-old female patient with rheumatoid arthritis affecting multiple joints who is rheumatoid-factor positive but without organ or system failure returns for her third infliximab infusion. She is scheduled to receive 500 mg of the drug. How should this encounter be coded? 96413, 96415, J1745 x 50; ICD 10: M05.79 96413, 96415, J1745 x 50;…

New ACR COIN Project Connects Volunteers to Patients in Greatest Need

Susan Bernstein  |  November 19, 2018

Improving access to rheumatology care for underserved patient populations is a priority for the ACR, and the subject of a major position statement by the Committee on Rheumatologic Care (CORC) in 2017. According to the ACR’s 2015 Workforce Study, the existing shortage of rheumatologists and rheumatology health professionals is expected to worsen in the next…

2018 Annual Meeting Attendees Receive Free ACR Beyond Subscription

From the College  |  November 19, 2018

All 2018 ACR/ARHP Annual Meeting attendees received a complimentary, one-year ACR Beyond Streaming subscription. Recipients have access to all of the recorded sessions from the Annual Meeting, as well as more than 500 sessions from past meetings. In addition, they have the opportunity to view recorded sessions from upcoming 2019 educational meetings, including the Winter…

Rheumatology Research Foundation Launches $75M Fundraising Push

From the College  |  November 19, 2018

The Rheumatology Research Foundation has embarked on its third and most ambitious fundraising campaign, with a goal of raising $75 million. The Leading Boldly: Transforming Rheumatology campaign will support Foundation programs to recruit the best and brightest into the field, train rheumatology health professionals at all career stages and support investigators conducting research that will…

The ACR Debuts Open Access Journal

Susan Bernstein  |  November 19, 2018

The ACR will add a new professional journal, ACR Open Rheumatology, in January 2019. An open access journal, it will feature the same high-quality, rigorously peer-reviewed articles on original investigations in rheumatology research, as well as commentaries and reviews, as the ACR’s other journals, Arthritis & Rheumatology (A&R) and Arthritis Care & Research (AC&R). Co-Editors-in-Chief…

Donah Zack Crawford in the Spotlight: Why the ARHP Is for Me

Kelly Tyrrell  |  November 18, 2018

Donah Zack Crawford, MA, was a research coordinator at the University of Pennsylvania, focused on pre­menstrual syndrome and peri­menopause, when her symptoms first started. “Someone suggested I see a rheumatologist,” she says, and not long after, Philadelphia-based physician Bruce Hoffman, MD, diagnosed her with rheumatoid arthritis. It was the mid-1990s, and treatment options were limited….

Quality Payment Program Year 3 Reporting Changes: What You Need to Know

From the College  |  November 13, 2018

The Centers for Medicare & Medicaid Services (CMS) released the final rule for the Quality Payment Program (QPP) year 3 (CY 2019) on Nov. 1, 2018. Below, we have compiled a list of key changes to ensure MIPS-eligible clinicians are accurately reporting for CY 2019: New MIPS-eligible clinician types: Physical therapist, occupational therapist, qualified speech-language…

2018 MIPS Reporting via RISE: Are You Ready?

From the College  |  November 5, 2018

It’s time to prepare for 2018 MIPS reporting via the Rheumatology Informatics System for Effectiveness (RISE) registry, and the ACR is here to help. To ensure you’re ready to submit your data to the CMS, RISE users should take the following steps: Complete the survey to notify the ACR of your intent to report via…

RheumPAC Champions Recognized

From the College  |  November 5, 2018

Election Day 2018 has come and gone, and a new class of legislators will be joining the ranks of Congress in January. RheumPAC is the most important tool we have to establish relationships with our new legislators and this year, our ACR volunteer leaders stepped up and matched all donations to RheumPAC leading up to…

CMS Proposes New Part B Drug Payment Model

From the College  |  November 2, 2018

Late last month, the Centers for Medicare & Medicaid Services (CMS) released an advance notice of proposed rulemaking (ANPRM), seeking feedback on a potential drug pricing model called the International Pricing Index (IPI) model. This comment solicitation is in alignment with the administration’s blueprint to lower drug costs and reduce out-of-pocket costs, and is an…

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 135
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences